Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guerin-unresponsive Non-muscle invasive Bladder Cancer: Con

被引：2
|
作者：
Grobet-Jeandin, Elisabeth [1 ,2 ]
Pinar, Ugo [1 ]
Roupret, Morgan [1 ]
机构：
[1] Sorbonne Univ, Pitie Salpetriere Hop, AP HP, GRC 5,Predict Oncourol, Paris, France
[2] Univ Hosp Geneva, Div Urol, Geneva, Switzerland
来源：
EUROPEAN UROLOGY FOCUS | 2022年 / 8卷 / 04期
关键词：
SINGLE-ARM; OPEN-LABEL; BCG; INTERFERON-ALPHA-2B; MULTICENTER; PEMBROLIZUMAB;
D O I：
10.1016/j.euf.2021.09.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1121 / 1123
页数：3
相关论文
共 50 条
  • [1] Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non-muscle-invasive bladder cancer: Pro
    Roumiguie, Mathieu
    Black, Peter C.
    EUROPEAN UROLOGY FOCUS, 2022, 8 (04): : 1117 - 1120
  • [2] Treatment strategies for the Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
    Jeong, Seung-hwan
    Ku, Ja Hyeon
    INVESTIGATIVE AND CLINICAL UROLOGY, 2023, 64 (02) : 103 - 106
  • [3] Role of immunotherapy in bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
    Mukherjee, Neelam
    Svatek, Robert S.
    Mansour, Ahmed M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (03) : 103 - 108
  • [4] Emerging treatment options for bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
    Kokorovic, Andrea
    Ory, Jesse
    Saad, Fred
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (01) : 48 - 53
  • [5] RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Escano, Manuel R. De Jesus
    Vertosick, Emily
    Benfante, Nicole
    Lenis, Andrew T.
    Reisz, Peter A.
    Goh, Alvin
    Cha, Eugene
    Donahue, Timothy F.
    Bochner, Bernard H.
    Sjoberg, Dan
    Pietzak, Eugene J.
    JOURNAL OF UROLOGY, 2021, 206 : E299 - E299
  • [6] Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy
    Iida, Kota
    Miyake, Makito
    Murakami, Kaoru
    Komiyama, Motokiyo
    Okajima, Eijiro
    Sazuka, Tomokazu
    Nishiyama, Naotaka
    Yasumoto, Hiroaki
    Kimura, Takahiro
    Ito, Akihiro
    Shiga, Kenichiro
    Yamagishi, Atsushi
    Kikuchi, Hiroshi
    Sugimoto, Mikio
    Taoka, Rikiya
    Kobayashi, Takashi
    Kojima, Takahiro
    Kitamura, Hiroshi
    Nishiyama, Hiroyuki
    Fujimoto, Kiyohide
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2104 - 2112
  • [7] Emerging treatments for bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer
    Kim, Hyung Suk
    Seo, Ho Kyung
    INVESTIGATIVE AND CLINICAL UROLOGY, 2021, 62 (04) : 361 - 377
  • [8] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Velaer, Kyla N.
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    Nepple, Kenneth G.
    CURRENT UROLOGY REPORTS, 2016, 17 (05)
  • [9] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Kyla N. Velaer
    Ryan L. Steinberg
    Lewis J. Thomas
    Michael A. O’Donnell
    Kenneth G. Nepple
    Current Urology Reports, 2016, 17
  • [10] BACILLUS CALMETTE-GUERIN VERSUS SEQUENTIAL GEMCITABINE AND DOCETAXEL FOR TA HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER
    Eraky, Ahmed
    Hug, Brenda
    Kolanukuduru, Kaushik P.
    Ben-David, Reuben
    Almoflihi, Mohammed
    Waigankar, Nikhil
    Attalla, Kyrollis
    Wiklund, Peter
    Mehrazin, Reza
    Sfakianos, John P.
    JOURNAL OF UROLOGY, 2025, 213 (5S):
12345